Skip to main content
. 2022 Oct 21;12(10):2564. doi: 10.3390/diagnostics12102564

Table 1.

Baseline characteristics of SAPH and SA patients. FVC % predicted: forced vital capacity % of predicted value; DLCO SB % predicted: single-breath diffusing capacity of the lung for carbon monoxide % predicted; Mean PAP: mean pulmonary arterial pressure; PVR: pulmonary vascular resistance; PCWP: pulmonary capillary wedge pressure; ND: parameter was not determined.

SAPH (n = 39) SA (n = 39) p-Value
Male, n (%) 19 (48.7) 19 (48.7) 1.00
Age mean (SD), y 59.2 (11.3) 60.9 (10.9) 0.50
Ancestry White, n (%) 27 (69.2) 27 (69.2) 1.00
Black, n (%) 9 (23.1) 9 (23.1)
Hindustan, n (%) 3 (7.7) 3 (7.7)
Scadding stage
(n = 38; n = 39)
0, n (%) 2 (5.3) 8 (20.5) 0.016
1, n (%) 4 (10.5) 3 (7.7)
2, n (%) 4 (10.5) 9 (23.1)
3, n (%) 2 (5.3) 6 (15.4)
4, n (%) 26 (68.4) 13 (33.3)
Lung fibrosis score
(n = 38; n = 39)
<5%, n (%) 9 (23.7) 22 (56.4) <0.001
5–20%, n (%) 1 (2.6) 7 (17.9)
>20%, n (%) 28 (73.7) 10 (25.6)
FVC % predicted, mean (SD) (n = 37; n = 36) 66.6 (19.4) 94.2 (23.1) <0.001
DLCO SB% predicted, mean, mean (SD)
(n = 32; n = 32)
47.8 (18.5) 68.4 (15.2) <0.001
Mean PAP mmHg, mean (SD) 37.4 (10.9) ND
PVR Wood units, mean (SD) (n = 36; ND) 5.6 (3.1) ND
Cardiac output L·min-1, mean (SD) (n = 38; ND) 5.7 (1.8) ND
PCWP mmHg, mean (SD) (n = 37; ND) 9.7 (3.6) ND